News coverage about RTI Surgical (NASDAQ:RTIX) has been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RTI Surgical earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 46.4169667913659 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

RTI Surgical (NASDAQ RTIX) traded down $0.15 during midday trading on Friday, hitting $4.40. The stock had a trading volume of 151,333 shares, compared to its average volume of 172,645. The firm has a market cap of $261.84, a PE ratio of -62.86, a P/E/G ratio of 2.02 and a beta of 1.76. RTI Surgical has a one year low of $3.01 and a one year high of $6.00. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.34 and a quick ratio of 1.21.

RTI Surgical (NASDAQ:RTIX) last released its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.01. The company had revenue of $66.69 million during the quarter, compared to analysts’ expectations of $65.63 million. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The firm’s revenue for the quarter was up .2% compared to the same quarter last year. equities research analysts forecast that RTI Surgical will post 0.05 earnings per share for the current year.

RTIX has been the subject of a number of recent analyst reports. Zacks Investment Research cut RTI Surgical from a “hold” rating to a “sell” rating in a report on Thursday, October 5th. BidaskClub raised RTI Surgical from a “strong sell” rating to a “sell” rating in a report on Saturday, January 6th.

COPYRIGHT VIOLATION WARNING: “RTI Surgical (RTIX) Given News Sentiment Rating of 0.13” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/rti-surgical-rtix-given-news-sentiment-rating-of-0-13/1805911.html.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.